Health News of Alabama: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health News of Alabama.

Press releases published on June 29, 2026

4 hours ago

Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength

Indeterminate GlobeNewswire

4 hours ago

Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results

Indeterminate GlobeNewswire

4 hours ago

BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder

Indeterminate GlobeNewswire

4 hours ago

Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer

Indeterminate GlobeNewswire

4 hours ago

Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer

Indeterminate GlobeNewswire

4 hours ago

Palvella Therapeutics Submits First Module of Rolling New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

Indeterminate GlobeNewswire

4 hours ago

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)

Indeterminate GlobeNewswire

4 hours ago

Dyadic Expands IP Protection and Business Development Activities in Japan

Indeterminate GlobeNewswire

5 hours ago

George Medicines appoints Brendan Walsh as Senior Vice President of Supply Chain & Technical Operations

Indeterminate GlobeNewswire

5 hours ago

Dr. Mariusz Sapijaszko elected President of the Canadian Dermatology Association

Indeterminate GlobeNewswire

5 hours ago

Le Dr Mariusz Sapijaszko élu président de l’Association canadienne de dermatologie

Indeterminate GlobeNewswire

5 hours ago

Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire

5 hours ago

Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire

5 hours ago

Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET

Indeterminate GlobeNewswire

5 hours ago

Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire

5 hours ago

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

Indeterminate GlobeNewswire

5 hours ago

NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company

Indeterminate GlobeNewswire

5 hours ago

BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility

Indeterminate GlobeNewswire

5 hours ago

Conavi Medical Receives $1.25 Million Milestone Payment Under Ontario Life Sciences Scale-Up Fund

Indeterminate GlobeNewswire

5 hours ago

NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

Indeterminate GlobeNewswire